Yahoo Finance • yesterday
Dublin, Dec. 23, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Regulatory Affairs in Asia Training Course (Mar 24th - Mar 26th, 2026)" training has been added to ResearchAndMarkets.com's offering. The pharmaceutical market in Asia is gr... Full story
Yahoo Finance • yesterday
Dublin, Dec. 23, 2025 (GLOBE NEWSWIRE) -- The "Vietnam System Integrator Market 2025-2031" has been added to ResearchAndMarkets.com's offering. The Vietnam System Integrator Market is experiencing significant growth fueled by the incre... Full story
Yahoo Finance • 2 days ago
929 MASS. Photo Credit: Atwater Media Productions BETHESDA, Md., December 22, 2025--(BUSINESS WIRE)--Walker & Dunlop Capital Markets announced today that it arranged the sale and financing of 929 MASS, a mixed-use, two-building property l... Full story
Yahoo Finance • 2 days ago
[Businesswoman with data analysis and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long-term investment for retirement. Interest rate and dividend concept.] Userba011d64_201 Bank of America Securities’... Full story
Yahoo Finance • 5 days ago
Anome Protocol and SentismAI partner. Ronin network activity slumps as its top game’s popularity declines. MetaArena outperforms its peers with a 25% weekly pump. The market is a bit more buoyant as the U.S. Senate confirmed Trump’s nomin... Full story
Yahoo Finance • 6 days ago
[Headquarters of ArcelorMittal France] HJBC As 2025 draws to a close, Wall Street has observed another strong year of gains across most sectors. The materials sector hasn't flown as high as its peers, but it is still +7.37% YTD. Its acco... Full story
Yahoo Finance • 6 days ago
Zurich, Switzerland, December 18, 2025 – MUVON Therapeutics, a clinical-stage biotechnology company focused on developing a novel platform for the regeneration of skeletal muscle tissue, announces the appointment of cell therapy pioneer Ch... Full story
Yahoo Finance • 7 days ago
MONTREAL, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Three of the biotech industry’s trusted advisory firms: KreaMedica, Venture Valuation, and Lacerta Bio, today announced the release of The First-Time Biotech CEO Playbook, a practical guide des... Full story
Yahoo Finance • 7 days ago
On track for initial clinical data in mid-2026Marks a pivotal step toward scalable, accessible, off-the-shelf cell therapies for solid tumours Oslo, Norway, 17 December 2025 – Zelluna (OSE: ZLNA), a company pioneering allogeneic off-the-s... Full story
Yahoo Finance • 7 days ago
Forventer første kliniske data fra midten av 2026Markerer et viktig skritt mot skalerbare, tilgjengelige "off-the-shelf" celleterapier for solide kreftformer Oslo, Norge, 17. desember 2025 – Zelluna (OSE: ZLNA), et bioteknologiselskap som... Full story
Yahoo Finance • 7 days ago
CEDARVILLE, OHIO, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Christmas is often described as the most wonderful time of the year—a season of warmth, connection, and celebration. But for the more than 11 million incarcerated individuals worldwide,... Full story
Yahoo Finance • 7 days ago
Ottawa, Dec. 17, 2025 (GLOBE NEWSWIRE) -- The global automated e-commerce packaging market reported a value of USD 852.75 million in 2025, and according to estimates, it will reach USD 2708.11 million by 2034, as outlined in a study from... Full story
Yahoo Finance • 8 days ago
SAN FRANCISCO, Dec. 16, 2025 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is issuing a reminder to investors in Telix Pharmaceuticals Ltd. (NASDAQ: TLX) that the deadline to move the Court for appointment as lea... Full story
Yahoo Finance • 9 days ago
Arbitration Ruling Reaffirms Allogene’s Full Control of Cemacabtagene Ansegedleucel (Cema-Cel)Decision Reconfirms Allogene’s Expanded Sub-License Covering EU and UK Rights with Options for Japan and China, Clearing the Path for Allogene to... Full story
Yahoo Finance • 10 days ago
STOCKHOLM, Dec. 15, 2025 /PRNewswire/ -- Swedish Orphan Biovitrum AB (STO: SOBI) recently announced that it has entered into an acquisition agreement with Arthrosi Therapeutics, Inc., which was invested in and incubated by Viva Biotech Hol... Full story
Yahoo Finance • 10 days ago
[Construction Crew Putting Up Framing of New Home] RyanJLane Cyclical stocks have rallied sharply in recent weeks, outperforming Defensives for a record 14-straight sessions before pulling back, according to Goldman Sachs. But despite th... Full story
Yahoo Finance • 12 days ago
New York, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released an Update Note on Ensysce Biosciences, Inc. (NASDAQ: ENSC). The resear... Full story
Yahoo Finance • 13 days ago
LOS ANGELES, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming January 9, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or other... Full story
Yahoo Finance • 13 days ago
Equity-backed commitment dramatically de-risks pivotal program, boosts licensing appeal, and strengthens commercialization readiness. HUNTINGTON, N.Y., Dec. 11, 2025 /PRNewswire/ -- Sen-Jam Pharmaceutical, a clinical-stage biotechnology c... Full story
Yahoo Finance • 13 days ago
International debut underscores emerging role for macrophage checkpoint therapy in gastric cancer, triple-negative breast cancer, and other hard-to-treat solid tumors TAIPEI, SHANGHAI, AND SAN FRANCISCO, Dec. 11, 2025 /PRNewswire/ -- Hanc... Full story